Do They Like My Post? A Three Arm Randomised Control Trial Investigating the Effect of Exposure to Body Positivity (Self-Love) Compared to Fitspiration Social Media Content on Female Adults’ Perceived Body Image.

Start Date15 Jun 2021

Sponsor / Collaborator

University of Auckland, Faculty of Medical and Health Sciences

100 Clinical Results associated with University of Auckland, Faculty of Medical and Health Sciences

0 Patents (Medical) associated with University of Auckland, Faculty of Medical and Health Sciences

185

Literatures (Medical) associated with University of Auckland, Faculty of Medical and Health Sciences

27 May 2025·Journal of the Royal Society of New Zealand

Audiology-led model provides efficient and effective access to grommet surgery

Article

Author: Hislop, Renee A. ; Wong, Jenna ; Pokorny, Michelle A. ; Mahadevan, Murali ; Johnston, James

Children with otitis media who are referred to paediatric otorhinolaryngology (ORL) departments often experience significant delays in treatment. Alternate models of care utilising audiologists with extended scopes of practice can potentially improve outcomes in services experiencing difficulties with high demand and insufficient ORL capacity. An Advanced Audiology Practitioner (AAP) service was implemented in Counties Manukau to combat known long wait times for children with otitis media. This study aimed to retrospectively evaluate the clinical and service outcomes of the 165 children referred to the AAP service during the initial 3 month period of operation. Engagement with the AAP service was high, with a 96% attendance rate at the first appointment. The proportion of children waiting longer than recommended (>120 days) for paediatric ORL appointments was reduced by 33%, and the average wait time for children seen in the AAP service was reduced from 196 to 14 days. The AAP model provided an efficient and effective clinical service, with 55% of children seen in a single visit and 91% of waitlisted children having middle ear effusion on myringotomy. In conclusion, the AAP model improves access to ORL treatment, particularly for children at risk for otitis media and associated hearing loss.

01 Mar 2025·Annals of Surgery

Outcomes Related to New Persistent Opioid Use After Surgery or Trauma

Article

Author: Beyene, Kebede ; Jones, Peter ; Frampton, Chris ; Chan, Amy Hai Yan ; Gong, Jiayi

Objectives:To evaluate the impact of persistent opioid use (POU) following surgery or trauma on health outcomes using linked data.Background:Surgery and trauma can lead to POU, characterized by continuous opioid consumption following hospital discharge. Outside the United States, there is a lack of population-based studies on POU outcomes in opioid-naive patients following these events.Methods:We included opioid-naïve patients who have dispensed opioids after being discharged following admission for surgery or trauma to any New Zealand (NZ) hospital from 2007 to 2019. Differences in outcomes between individuals with and without POU were assessed between 180 and 360 days after discharge. The primary outcome was all-cause mortality, the secondary outcomes were all-cause and opioid-related hospitalization, and Days Alive and Out of Hospital (DAOH). Cox and quantile multivariable regression models were used to examine the association between POU and outcomes.Results:Overall, 298,928 surgical and 206,663 trauma patients were included in the final analyses, and 17,779 (5.9%) surgical and 17,867 (8.6%) trauma patients developed POU. POU was significantly associated with increased risk of all-cause mortality (surgical, aHR=6.59; 95% CI: 5.82–7.46; trauma, aHR=2.77; 95% CI: 2.47–3.11), all-cause hospitalization (surgical, aHR=2.02; 95% CI: 1.95–2.08; trauma, aHR=1.57; 95% CI: 1.52–1.62), opioid-related hospitalization (surgical, aHR=2.49; 95% CI: 2.24–2.76; trauma, aHR=1.89; 95% CI: 1.73–2.05) and reduced DAOH.Conclusions:Among opioid-naive patients who received opioids after surgery or trauma, POU was associated with worse outcomes, including increased mortality. Further investigation is warranted to understand the reasons for continued opioid use beyond 90 days and mechanisms associated with harm.

01 Mar 2025·BMJ Open

Long-term lived experiences of patients with chronic pain or angina pectoris treated with spinal cord stimulation: a qualitative study

Article

Author: Jowsey, Tanisha ; Sleigh, Jamie ; Moore, Matthew ; Merry, Alan Forbes ; Ramakrishna, Shashikala ; Davies, Elaine

ObjectiveTo explore the short-term and long-term lived experiences of patients with chronic pain and angina pectoris with spinal cord stimulation.DesignAn interpretive qualitative study with thematic analysis of one-off, semistructured interviews, following Braun and Clarke (2006).SettingA multidisciplinary, publicly funded pain service in Auckland, New Zealand. Patients usually undergo a comprehensive medical, psychological and functional assessment and an in-house pain management programme before proceeding to spinal cord stimulator implantation.ParticipantsParticipants implanted with a spinal cord stimulator between 1998 and 2019 who had their stimulator for ≥1 year, purposively sampled to increase the range of ethnicities.Main outcomeThe themes identified from the interviews.Results24 participants with chronic pain of varied aetiology and a median (range) of 5.2 (2.4–23.2) years since stimulator implantation participated. 22 participants had the device in situ, and 2 had been explanted. Five main themes were identified: (1) embodiment: stimulator and body as one; (2) technical factors: batteries and type of stimulation; (3) improved well-being; (4) social connection and (5) healthcare system interaction. Most participants reported pain relief, but many had experienced complications and discomfort. They emphasised the importance of ongoing support from the pain service. Acceptance of pain, coping and embodiment emerged as common motifs across these themes. 21 participants were satisfied with their treatment.ConclusionWithin the context of a multidisciplinary pain clinic, despite some discomfort and various complications, most participants valued the ongoing reduction of pain achieved with spinal cord stimulation. Timely access to support from the pain service influenced their experience and satisfaction with their stimulators. Acceptance of pain and embodiment of the stimulator helped participants adapt to living with their stimulator, often over many years.

100 Deals associated with University of Auckland, Faculty of Medical and Health Sciences

100 Translational Medicine associated with University of Auckland, Faculty of Medical and Health Sciences

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 10 May 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

TBAJ-587 ( mycobacterial ATP synthase )	Tuberculosis More	Pending

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

Chat with Hiro

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis